Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

<div>Effect on PEL cell cytotoxicity of p38, JNK, or ERK inhibition by SB203580, SP600125, and PD98059, respectively, based on trypan blue exclusion is reported. The treatment was performed for 24 hours at the concentration of 10 <i>μ</i>M. All the reagents were purchased from Santa Cruz. The mean ± SD of three independent experiments is reported.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future 